World's Best Scientists 2026 revealed!
Clinical Pharmacokinetics
H-index 31

Clinical Pharmacokinetics

0312-5963

Published by: Springer

https://www.springer.com/journal/40262

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 790 113 169 27

Additional Metrics

Number of Best Scientists*: 160
Documents by Best Scientists*: 206
Top 100 Ranked Scientists*: 4
SCIMAGO H-index: 191
SCIMAGO SJR: 1.305
Impact Factor: 4

Overview

Top Research Topics at Clinical Pharmacokinectics?

The journal facilitates discussions on Pharmacokinetics, Pharmacology, Internal medicine, Pharmacotherapy and Drug. It focuses on Pharmacokinetics but the discussions also offer insight into other areas such as Oral administration, Anesthesia and Bioavailability. It dives deep in exploring the relationship between the study of Oral administration and Cmax.

The study on Pharmacology presented in it intersects with subjects under the field of Metabolite. In it, Gastroenterology, Endocrinology and Oncology are investigated in conjunction with one another to address concerns in Internal medicine research. Antibiotics, Clinical trial, Surgery, Intensive care medicine and Pharmacology toxicology are some topics wherein Pharmacotherapy research discussed in Clinical Pharmacokinectics have an impact.

More specifically, the research on Antibiotics in Clinical Pharmacokinectics is related to Antibacterial agent. Drug research is the primary subject tackled in Clinical Pharmacokinectics with a focus on Drug metabolism. The Renal function study featured in it draws connections with the study of Urology.

  • Pharmacokinetics (71.19%)
  • Pharmacology (61.23%)
  • Internal medicine (26.26%)

What are the most cited papers published in the journal?

  • Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. (1166 citations)
  • Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. (1031 citations)
  • PEGYLATION: A NOVEL PROCESS FOR MODIFYING PHARMACOKINETICS (830 citations)

Research areas of the most cited articles at Clinical Pharmacokinectics:

The most cited papers primarily focus on research topics in Pharmacokinetics, Pharmacology, Drug, Internal medicine and Endocrinology. The studies on Pharmacokinetics discussed at the published articles can also contribute to research in the domains of Oral administration, Pharmacotherapy and Bioavailability. The most cited articles with studies in Pharmacology featured incorporate elements of Intestinal absorption and Metabolite.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Pharmacology
  • Cancer

The previous edition focused in particular on these issues:

The topics of Pharmacokinetics, Internal medicine, Pharmacology, Pharmacotherapy and Dosing are the focal point of discussions in the journal. The Pharmacokinetics works featured in Clinical Pharmacokinectics incorporate elements from Urology and Renal function. Topics in Renal function were tackled in line with various other fields like Creatinine, Anesthesia, Vancomycin and Antibiotics.

Topics in Internal medicine explored in the journal were investigated in conjunction with research in Gastroenterology, Endocrinology and Oncology. Research on Pharmacology presented in the journal focuses, in particular, on Drug, Bioavailability, Distribution (pharmacology), Area under the curve and Oral administration. The journal explores topics in Pharmacotherapy which can be helpful for research in disciplines like Clozapine, MEDLINE, Intensive care medicine, Hypersalivation and Pharmacology toxicology.

The most cited articles from the last journal are:

  • Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor. (12 citations)
  • Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil. (7 citations)
  • Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical Pharmacokinectics (based on the number of publications) are:

  • Alwin D. R. Huitema (41 papers) published 6 papers at the last edition, 1 less than at the previous edition,
  • Jos H. Beijnen (39 papers) published 3 papers at the last edition, 2 less than at the previous edition,
  • Catherijne A. J. Knibbe (35 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Mary H H Ensom (33 papers) absent at the last edition,
  • Meindert Danhof (26 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical Pharmacokinectics (based on the number of publications) are:

  • Boston Children's Hospital (78 papers) published 10 papers at the last edition, 1 less than at the previous edition,
  • Utrecht University (68 papers) published 11 papers at the last edition, 3 more than at the previous edition,
  • Radboud University Nijmegen (56 papers) published 7 papers at the last edition, 3 less than at the previous edition,
  • Leiden University (55 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • University of Queensland (52 papers) published 5 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.43% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.01% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.16% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 22.90% of all publications and 38.93% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Required Education for Clinical Pharmacokinetics

Clinical Pharmacokinetics is a scientific discipline that deals with the absorption, distribution, metabolism, and elimination of drugs within the body. Gaining a deep understanding of these principles allows professionals to effectively manage medication therapies and improve patient outcomes. While the elements of this field are intricate, the rewards it offers in terms of career opportunities are vast. Opportunities in Clinical Pharmacokinetics extend to roles such as clinical research pharmacologist, pharmacokineticist, clinical trial lead, and many more. These professionals work in different settings, including hospitals, pharmaceutical companies, and research institutions. To venture into this field, a strong foundation in science is crucial, followed by specialized training or education related to the specific aspects of Clinical Pharmacokinetics. For those interested in the nursing field, learning about pharmacokinetics is essential as it helps understand how drugs work in the body, which is critical in patient care. It is advisable to consider undertaking a Bachelor of Science in Nursing (BSN) degree, then pursue further study and specialization in Clinical Pharmacokinetics or Pharmacology. Online nursing programs are a great way to achieve this without compromising current professional commitments if any. They combine the convenience of learning at your own pace coupling with the rigorous academics associated with traditional on-campus programs. An example of such a program is best online nursing programs in texas. Ultimately, branching into Clinical Pharmacokinetics can pave the way for rewarding careers in healthcare and pharmaceuticals. Further education and continuous learning in this field can open up more avenues, enhancing career prospects and contributing significantly to patient care.

Top Publications

  • Drug-Drug Interactions with Direct Oral Anticoagulants

    Kathrin I. Foerster;Simon Hermann;Gerd Mikus;Walter Emil Haefeli

    (2020)
    89 Citations
  • Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics

    Beatrijs I. Valk;Michel M. R. F. Struys;Michel M. R. F. Struys

    (2021)
    86 Citations
  • Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

    Daryl Hodge;David J. Back;Sara Gibbons;Saye H. Khoo

    (2021)
    80 Citations
  • Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus

    (2020)
    65 Citations
  • Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression

    (2020)
    64 Citations
  • Pharmacokinetic Alterations Associated with Critical Illness

    (2023)
    60 Citations
  • Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib.

    Stefanie L Groenland;Alejandra Martínez-Chávez;Marloes G J van Dongen;Jos H Beijnen;Jos H Beijnen

    (2020)
    60 Citations
  • Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology

    (2022)
    56 Citations
  • Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor

    Angela Joubert James;Catherine C. Smith;Mark Litzow;Alexander E. Perl

    (2020)
    53 Citations
  • SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.

    Ethan Hoffmann;George G. Nomikos;George G. Nomikos;Inder Kaul;Shane Raines

    (2020)
    53 Citations

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA, exploring related online degrees can open doors to diverse healthcare careers. Many professionals enhance their expertise through certificate programs, such as the shortest post master's pmhnp online programs, which offer a focused pathway into psychiatric mental health nursing.

Similarly, aspiring family nurse practitioners may consider the fastest post master's fnp certificate programs that provide accelerated training for advanced practice roles. These options are particularly valuable for busy professionals seeking streamlined paths to career advancement.

Nutrition and dietetics represent another vital area linked to medicine, with many online options available. Students can find affordable education opportunities through the dietitian degree online programs, allowing them to specialize in dietary health and wellness.

For registered nurses aiming to further their education, there are numerous online RN to BSN options that balance flexibility and quality. The online rn to bsn programs are designed to help nurses obtain their bachelor's degree efficiently, enhancing their clinical expertise and career prospects.

Best Scientists Contributing to This Journal

Recently Published Articles